Open original FDA record ↗Recall record
- FDA identifier
- Z-1585-2026
- Company in FDA record
- Diagnostica Stago, Inc.
- FDA classification date
- Mar 19, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range.
Source facts
- Action
- On February 5, 2026 QUALITY ALERT letters were emailed to customers. Actions required: 1. As the intended purpose of the kit is to exclude PE and DVT, and its sensitivity and negative predictive value remain unchanged, it is appropriate to continue utilizing the reagents. 2. Please complete, sign and return the attached Acknowledgement Form by email, as directed on the form. In the event that a patient experiences an adverse event with any medical device, you may report it to FDA; see the guidance document Medical Device Reporting for User Facilities, which is available on the FDA.gov website, for instructions. For additional information, please contact Stago s 24/7 Hotline at 1-800-725-0607.
- Initiated
- 2026-02-05
- Root cause
- Process change control
- Distribution
- Worldwide distribution - US Nationwide and the countries of Canada, Singapore, Guam, Japan, South Korea, and Russia.
- Recall number
- Z-1585-2026
- Recall status
- Open, Classified
- CDRH record ID
- 218462
- FDA classified
- 2026-03-19
- Recall event number
- 98362